READCOOR
DEAD

Serial Number

88712433

Owner

ReadCoor, Inc.

Attorney

John Paul Oleksiuk

Filing Date

Dec 2, 2019

Add to watchlist:

No watchlists yet
View on USPTO

READCOOR Trademark

Serial Number: 88712433

READCOOR is a trademark filed by ReadCoor, Inc. on December 2, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

ReadCoor, Inc. (2 trademarks)

Pleasanton, CA 94588

Entity Type: 03

Trademark Details

Filing Date

December 2, 2019

Registration Date

Not Registered

Published for Opposition

October 6, 2020

Goods & Services

Educational services, namely, providing seminars, workshops, customer trainings and tutorials in the fields of and for use in the fields of nucleic acid sequencing and genotyping, medical diagnostics, clinical diagnostics, medical research, clinical research, life sciences, biology, genetics, and biotechnology; Providing non-downloadable electronic newsletters and online electronic newsletters delivered via email for use in the fields of nucleic acid sequencing and genotyping, medical diagnostics, clinical diagnostics, medical research, clinical research, life sciences, biology, genetics, and biotechnology; Educational services, namely, providing training of clinicians, scientists, researchers and medical professionals for certification in the use of scientific equipment and instruments, namely, genomic sequencers and molecular diagnostics apparatus; Providing facilities for training in operation and use of scientific equipment and instruments, namely, genomic sequencers and molecular diagnostics apparatus

Downloadable software for use in analyzing, managing and visualizing DNA sequencing, antibodies, proteins, and therapeutic detection data; downloadable computer software for implementing an algorithm used to analyze, manage and visualize multiple types of data from one or more cells; downloadable computer software for use in analyzing, managing, visualizing multiple types of data from one or more individual cells; laboratory devices for detecting expression of genetic sequences

Medical diagnostic reagents

Financing services; Warranty services, namely, providing extended warranties on laboratory equipment, namely, genomic sequencers and molecular diagnostics, scientific apparatus and instruments, namely, genomic sequencers and molecular diagnostics

Promoting collaboration and the exchange of information and resources within the cooperative scientific, research, medical, and provider community to achieve advances in the fields of nucleic acid sequencing and genotyping, medical diagnostics, clinical diagnostics, medical research, clinical research, life sciences, biology, genetics, and biotechnology

Chemicals and reagents for scientific use; diagnostic chemical and biological reagent kits consisting primarily of probes, buffers, amplifiers and/or other reagent components used for molecular testing for clinical diagnostics, scientific or research purposes; diagnostic reagents for clinical or medical laboratory use

Online social networking services

Medical diagnostic testing and reporting services in the fields of DNA sequencing, RNA and DNA analysis, antibodies, proteins, therapeutic detection, and genetic analysis; medical diagnostic testing, monitoring, and reporting services; medical diagnostic testing and reporting services

Clinical and medical diagnostic instruments, namely, nucleic acid sequencers

Design and development of computer software; Laboratory research services in the fields of DNA sequencing, RNA and DNA analysis, antibodies, proteins, therapeutic detection, and genetic analysis; scientific and laboratory research services for others in the field of DNA detection and sequencing, RNA detection and sequencing, protein detection, therapeutic detection, and analysis of spatial and functional relationships of analytes including DNA, RNA, proteins, therapeutics and structure; genomic and transcriptomic mapping for scientific purposes; research and product development services in the field of biotechnology; molecular testing and services, namely, clinical diagnostics, scientific research, custom design and development of molecular assays, and processing and analysis of molecular assays; chemical analysis; providing temporary use of online non-downloadable software for use in analyzing, managing and visualizing DNA sequencing, antibodies, proteins, and therapeutic detection data; providing temporary use of online non-downloadable computer software for implementing an algorithm used to analyze, manage and visualize multiple types of data from one or more cells; providing temporary use of online non-downloadable computer software for use in analyzing, managing, visualizing multiple types of data from one or more individual cells

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 6, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 5, 2021 ABN6
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 9, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 9, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 9, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 9, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 9, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 9, 2021 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 1, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 6, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 6, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 16, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 1, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 29, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 28, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 28, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 6, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 6, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 6, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 3, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 7, 2019 NWOS
NEW APPLICATION ENTERED
Dec 5, 2019 NWAP